SlideShare a Scribd company logo
Electronic cigarettes:Electronic cigarettes:
how should public healthhow should public health
respond?respond?
Linda BauldLinda Bauld
With thanks to
Maciej L. Goniewicz,
John Britton, Robert West
& Martin Dockrell
BackgroundBackground
 In order to consider how and where e-cigarettesIn order to consider how and where e-cigarettes
feature in the current public health landscape,feature in the current public health landscape,
it’s important to take into account recentit’s important to take into account recent
developments indevelopments in tobacco harm reductiontobacco harm reduction
 Harm reduction measures are aimed at thoseHarm reduction measures are aimed at those
smokers who, for whatever reason, are not ablesmokers who, for whatever reason, are not able
or willing toor willing to stop using tobaccostop using tobacco oror stop using nicotine.stop using nicotine.
BackgroundBackground
NICE & Licensed Nicotine Products
 The harm reduction approaches in the NICE guidanceThe harm reduction approaches in the NICE guidance
can involve substituting the nicotine in tobacco withcan involve substituting the nicotine in tobacco with
nicotine from less harmful, nicotine-containing products.nicotine from less harmful, nicotine-containing products.
 These include NRT products that are licensed by theThese include NRT products that are licensed by the
MHRA as pharmaceutical treatments for smoking.MHRA as pharmaceutical treatments for smoking.
 There are also unregulated products such as electronicThere are also unregulated products such as electronic
cigarettes. The guidance only recommends use of licensedcigarettes. The guidance only recommends use of licensed
products recognising that when electronic cigarettesproducts recognising that when electronic cigarettes
become licensed, they can be recommended for use.become licensed, they can be recommended for use.
 Nicotine-containing products might be used eitherNicotine-containing products might be used either
temporarily or indefinitely and as a partial or completetemporarily or indefinitely and as a partial or complete
substitute for tobaccosubstitute for tobacco
NICE & Nicotine-containing productsNICE & Nicotine-containing products
The guidance states that:The guidance states that:
There is reason to believe that lifetime use of licensedThere is reason to believe that lifetime use of licensed
nicotine-containing products will be considerably lessnicotine-containing products will be considerably less
harmful than smokingharmful than smoking
There is little direct evidence on the effectiveness, qualityThere is little direct evidence on the effectiveness, quality
and safety of nicotine-containing products that are notand safety of nicotine-containing products that are not
regulated by the MHRA. However, they are expected to beregulated by the MHRA. However, they are expected to be
less harmful than tobacco.less harmful than tobacco.
Hon Lik: inventor of the Ruyan (“Hon Lik: inventor of the Ruyan (“resembling smoking”resembling smoking” ))
e-cigarette, marketed 2004e-cigarette, marketed 2004
Anatomy ofAnatomy of anan e-cigarettee-cigarette
Development of devicesDevelopment of devices
Growth in useGrowth in use
 There are now an estimated 2.1 million users in the UKThere are now an estimated 2.1 million users in the UK
 In the Republic of Ireland in 2012 the EurobarometerIn the Republic of Ireland in 2012 the Eurobarometer
survey found that 3% of the Irish population had eversurvey found that 3% of the Irish population had ever
tried e-cigarettes and 1% used them regularlytried e-cigarettes and 1% used them regularly
 In the UK by 2014 ever use rose by a factor of 1.9 andIn the UK by 2014 ever use rose by a factor of 1.9 and
current use by 1.7. If a similar rise happened in Ireland,current use by 1.7. If a similar rise happened in Ireland,
we can assume 1.7% of the population regularly use ecigswe can assume 1.7% of the population regularly use ecigs
and 5.6% have ever tried themand 5.6% have ever tried them
 Amongst smokers in Ireland, we can estimate that aroundAmongst smokers in Ireland, we can estimate that around
1/3 (34%) have tried them but the figure may now be1/3 (34%) have tried them but the figure may now be
higher.higher.
Source: Eurobarometer and personal correspondence with Fenton Howell
Stop smoking aids (England)Stop smoking aids (England)
Source: West et al (2014)
www.smokinginengland.info/lateststatistics
20% use NRT from store
25% use e-cig
40% use nothing
• nicotine
• propylen glycol
• glycerin
• water
• flavourings
What is in a cartridge ?
• The Food and Drug Administration (FDA) has classified PG as an additive
that is “generally recognized as safe” for use in food.
• It is used to absorb extra water
and maintain moisture in certain
medicines, cosmetics, or food
products.
• PG is also used to create
artificial smoke or fog used
in theatrical productions.
• PG is practically odorless
and tasteless.
PropylenPropylenee GlycolGlycol
Current e-cigarette use amongCurrent e-cigarette use among
adults in England 2014adults in England 2014
13
ASH/YouGov March April 2014, Sample in England 10,112
Nicotine use by never smokersNicotine use by never smokers
and long-term ex-smokersand long-term ex-smokers
Source: West et al, 2014 N=5,272 from Nov 2013
E-cigarette use by never smokers is negligible
Use by children?Use by children?
Survey of children in GB 2013Survey of children in GB 2013
95%
90%
4%
8%
1%
1%
0%
1%
0% 25% 50% 75% 100%
11to15(N=804)16to18(N=624)
I use them often
(more than once a
week)
I use them sometimes
(more than once a
month)
I have tried them once
or twice
I have never used
them
99%
92%
82%
74%
59%
39%
8%
7%
18%
37%
48%
6%
4%
7%4%
5%
0%
25%
50%
75%
100%
Never
smoked
Tried smoking
once
Used to
smoke
Smoke <1 a
week
Smoke 1-6 a
week
Smoke 6+ a
week
Don't know/
Wouldn't say
I use them often
(more than once a
week)
I use them
sometimes (more
than once a month)
I have tried them
once or twice
I have never used
them
Source: ASH, 2014
Frequency of e-cigarette
use amongst 11-18 year olds
who had ever heard of
e-cigs
E-cigarette use by smoking
status, 11-18 year olds
E-cigarette/smoking by children: USAE-cigarette/smoking by children: USA
Source: US CDC data from National Youth Tobacco Survey 2011 and 2012. Graph from Bates & Rodu
E-cigarette marketingE-cigarette marketing
E-cigarette marketingE-cigarette marketing
Do e-cigarettes deliver nicotine?
E-cigarettes generate vapor that contains nicotine, but e-cigarettes brands
and models differ in efficacy and consistency of nicotine vaporization.
In e-cigarettes that vaporize nicotine effectively, the amount inhaled from
15 puffs is lower than smoking a conventional cigarette.
Toxicants in e-cigarettes?Toxicants in e-cigarettes?
 Other than nicotine, whatOther than nicotine, what
else do e-cigarettes deliver?else do e-cigarettes deliver?
 A number of studies haveA number of studies have
looked at this, with at least 8looked at this, with at least 8
toxic compounds identifiedtoxic compounds identified
 However all of these were atHowever all of these were at
significantly lower levels thansignificantly lower levels than
in conventional cigarettesin conventional cigarettes
• Small study conducted by Goniewcz and colleagues involving 20 tobacco cigarette
smokers
• Subjects were provided with electronic cigarettes with cartridges containing nicotine
• Subjects were asked to substitute their regular cigarettes with e-cigarettes for 2 weeks
• Researchers measured nicotine and selected carcinogens in their bodies
Exposure to toxicantsExposure to toxicants
after switchingafter switching
Nicotine & Tobacco-specificNicotine & Tobacco-specific
NitrosaminesNitrosamines
What about the vapour?What about the vapour?
 Should we be concerned about e-cigaretteShould we be concerned about e-cigarette
vapour in enclosed public places?vapour in enclosed public places?
 Lab studies suggest that the vapour containsLab studies suggest that the vapour contains
nicotine and some toxic metals such as cadium,nicotine and some toxic metals such as cadium,
nickel and lead, but levels are much lower thannickel and lead, but levels are much lower than
in second hand smokein second hand smoke
 No current evidence of health harms fromNo current evidence of health harms from
occasional exposureoccasional exposure
 However the effects of regular exposure overHowever the effects of regular exposure over
many years is unknown.many years is unknown.
Cessation: RCTs of E-cigarettesCessation: RCTs of E-cigarettes
• ‘‘Categoria’ 7.2mg nicotine EC vs. 4.8mgCategoria’ 7.2mg nicotine EC vs. 4.8mg
nicotine EC vs. no nicotine ECnicotine EC vs. no nicotine EC
 300 smokers (unwilling to quit)300 smokers (unwilling to quit)
 1 year abstinence rates: 13%, 9% and 4%1 year abstinence rates: 13%, 9% and 4%
(Caponnetto et al. 2013)(Caponnetto et al. 2013)
• ‘‘Elusion’ 16mg nicotine EC vs. nicotineElusion’ 16mg nicotine EC vs. nicotine
patch vs. no nicotine ECpatch vs. no nicotine EC
 657 participants657 participants
 6 month abstinence rates: 7.3%, 5.8% and6 month abstinence rates: 7.3%, 5.8% and
4.1%4.1%
(Bullen et al. 2013)(Bullen et al. 2013)
Effectiveness in EnglandEffectiveness in England
Source: West et al (2014)
www.smokinginengland.info/lateststatistics
E-cigarette users were more likely
not to be smoking than those using
NRT bought from a store and those
using nothing
**
** Significantly different from both other groups
After adjusting for differencesAfter adjusting for differences
between groupsbetween groups
Source: West et al (2014)
www.smokinginengland.info/lateststatistics
The odds of e-cigarette users still
being abstinent were 61% greater
than those using nothing and 63%
greater than those using NRT
Success rates of differentSuccess rates of different
methods of quittingmethods of quitting LowestLowest
 Nothing or NRT bought from aNothing or NRT bought from a
storestore
 HigherHigher
 Prescription NRT/medicine or e-Prescription NRT/medicine or e-
cigarette from a store (about 50%cigarette from a store (about 50%
better)better)
 HighestHighest
 Specialist support from NHSSpecialist support from NHS
Stop-Smoking Service (aboutStop-Smoking Service (about
200% better)200% better)
There has been an increase in the
rate of quitting smoking
More smokers are quittingMore smokers are quitting
•Source: West et al, 2014 ENGLAND ONLY Base: All adults
Cigarette consumption has decreased
as has overall nicotine use
Fewer people are using nicotineFewer people are using nicotine
•Source: West et al, 2014 ENGLAND ONLY Base: All adults
Cigarette smoking prevalenceCigarette smoking prevalence
Source: West et al, 2014 ENGLAND ONLY Base: All adults
Prevalence is declining faster than in
previous years since 2008
A licensed product?A licensed product?
NicoventuresNicoventuresVokeVoke inhaled nicotineinhaled nicotine
RegulationRegulation
 Medicine’s “walledMedicine’s “walled
garden”?garden”?
• ““Safe” and “effective”Safe” and “effective”
• Therapeutic doseTherapeutic dose
• AdvertisingAdvertising
• VAT 5%VAT 5%
 EU’s “NicotineEU’s “Nicotine
Jungle”?Jungle”?
• Health warning on packHealth warning on pack
• Concentration capConcentration cap
• No health claimsNo health claims
• Ad banAd ban
• 20% VAT20% VAT
• Declaration of additivesDeclaration of additives
Points for discussionPoints for discussion
• In the struggle to reduce preventable mortality, how do weIn the struggle to reduce preventable mortality, how do we
balance the risks?balance the risks?
• What are the ongoing evidence needs and how do we addressWhat are the ongoing evidence needs and how do we address
them?them?
• Do we need to test diverse responses or do we need a “oneDo we need to test diverse responses or do we need a “one
size fits all” international response now?size fits all” international response now?
• How do we manage tobacco industry involvement and whatHow do we manage tobacco industry involvement and what
scope is there to use the Framework Convention on Tobaccoscope is there to use the Framework Convention on Tobacco
Control?Control?
Thank youThank you
Linda.Bauld@stir.ac.ukLinda.Bauld@stir.ac.uk

More Related Content

What's hot

Effects of alternative nicotine delivery systems on cigarette consumption and...
Effects of alternative nicotine delivery systems on cigarette consumption and...Effects of alternative nicotine delivery systems on cigarette consumption and...
Effects of alternative nicotine delivery systems on cigarette consumption and...
Clive Bates
 
Accelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco UseAccelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco Use
Georgia State School of Public Health
 
The case of nicotine
The case of nicotineThe case of nicotine
The case of nicotine
Georgi Daskalov
 
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine FlahaultE-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
Lindsay Fox
 
E-cigarettes in America
E-cigarettes in AmericaE-cigarettes in America
E-cigarettes in America
amanda_richardson2
 
Changing Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
Changing Lifestyle Lessons from Tobacco Control | Prof Linda BauldChanging Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
Changing Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
Scottish Cancer Prevention Network
 

What's hot (6)

Effects of alternative nicotine delivery systems on cigarette consumption and...
Effects of alternative nicotine delivery systems on cigarette consumption and...Effects of alternative nicotine delivery systems on cigarette consumption and...
Effects of alternative nicotine delivery systems on cigarette consumption and...
 
Accelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco UseAccelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco Use
 
The case of nicotine
The case of nicotineThe case of nicotine
The case of nicotine
 
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine FlahaultE-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
E-Cigarettes a Disruptive Public Health Phenomenon - Professor Antoine Flahault
 
E-cigarettes in America
E-cigarettes in AmericaE-cigarettes in America
E-cigarettes in America
 
Changing Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
Changing Lifestyle Lessons from Tobacco Control | Prof Linda BauldChanging Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
Changing Lifestyle Lessons from Tobacco Control | Prof Linda Bauld
 

Similar to E-Cigarettes - How should Public Health respond? - Linda Bauld

Benefits of Electronic Cigarettes
Benefits of Electronic CigarettesBenefits of Electronic Cigarettes
Benefits of Electronic Cigarettes
Inlyte eCigs
 
0248
02480248
Nicotine Rapid Test Kit Presentation
Nicotine Rapid Test Kit PresentationNicotine Rapid Test Kit Presentation
Nicotine Rapid Test Kit Presentation
Pammvi Group of Companies
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
Brian Piper
 
E-Cigarettes - The untold truth
E-Cigarettes - The untold truthE-Cigarettes - The untold truth
E-Cigarettes - The untold truth
Ashraf ElAdawy
 
E-Cigarettes - how should Public Health respond - Martin Dockrell
E-Cigarettes - how should Public Health respond - Martin DockrellE-Cigarettes - how should Public Health respond - Martin Dockrell
E-Cigarettes - how should Public Health respond - Martin Dockrell
Institute of Public Health in Ireland
 
Final Draft 8
Final Draft 8Final Draft 8
Final Draft 8
Rebecca Ngo
 
Tobacco Harm Reduction_Crimson Publishers
Tobacco Harm Reduction_Crimson PublishersTobacco Harm Reduction_Crimson Publishers
Tobacco Harm Reduction_Crimson Publishers
CrimsonpublishersTTEH
 
e cig
e cige cig
E-cigarettes: pros, cons and controversy
E-cigarettes: pros, cons and controversy E-cigarettes: pros, cons and controversy
E-cigarettes: pros, cons and controversy
Laura-Jane Smith
 
E cigerrates
E cigerratesE cigerrates
E cigerrates
shrutikhare17
 
E cigerrates
E cigerratesE cigerrates
E cigerrates
shrutikhare17
 
dis
disdis
Vapours vs cigarettes research
Vapours vs cigarettes researchVapours vs cigarettes research
Vapours vs cigarettes research
wolllfie
 
E-Cigarettes: An Evidence Update
E-Cigarettes: An Evidence UpdateE-Cigarettes: An Evidence Update
E-Cigarettes: An Evidence Update
LynneDawkins
 
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
Clive Bates
 
E-cigarettes, California, basic information and legislative and regulatory su...
E-cigarettes, California, basic information and legislative and regulatory su...E-cigarettes, California, basic information and legislative and regulatory su...
E-cigarettes, California, basic information and legislative and regulatory su...
Kath OConnor
 
E-cig/Vaping fundamentals and CA legislation Aug 2014
E-cig/Vaping fundamentals and CA legislation Aug 2014E-cig/Vaping fundamentals and CA legislation Aug 2014
E-cig/Vaping fundamentals and CA legislation Aug 2014
Kath OConnor
 
How dangerous are e cigarette.pdf
How dangerous are e cigarette.pdfHow dangerous are e cigarette.pdf
How dangerous are e cigarette.pdf
James Brown
 
Tobacco Harm Reduction - an introduction
Tobacco Harm Reduction - an introductionTobacco Harm Reduction - an introduction
Tobacco Harm Reduction - an introduction
Clive Bates
 

Similar to E-Cigarettes - How should Public Health respond? - Linda Bauld (20)

Benefits of Electronic Cigarettes
Benefits of Electronic CigarettesBenefits of Electronic Cigarettes
Benefits of Electronic Cigarettes
 
0248
02480248
0248
 
Nicotine Rapid Test Kit Presentation
Nicotine Rapid Test Kit PresentationNicotine Rapid Test Kit Presentation
Nicotine Rapid Test Kit Presentation
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
E-Cigarettes - The untold truth
E-Cigarettes - The untold truthE-Cigarettes - The untold truth
E-Cigarettes - The untold truth
 
E-Cigarettes - how should Public Health respond - Martin Dockrell
E-Cigarettes - how should Public Health respond - Martin DockrellE-Cigarettes - how should Public Health respond - Martin Dockrell
E-Cigarettes - how should Public Health respond - Martin Dockrell
 
Final Draft 8
Final Draft 8Final Draft 8
Final Draft 8
 
Tobacco Harm Reduction_Crimson Publishers
Tobacco Harm Reduction_Crimson PublishersTobacco Harm Reduction_Crimson Publishers
Tobacco Harm Reduction_Crimson Publishers
 
e cig
e cige cig
e cig
 
E-cigarettes: pros, cons and controversy
E-cigarettes: pros, cons and controversy E-cigarettes: pros, cons and controversy
E-cigarettes: pros, cons and controversy
 
E cigerrates
E cigerratesE cigerrates
E cigerrates
 
E cigerrates
E cigerratesE cigerrates
E cigerrates
 
dis
disdis
dis
 
Vapours vs cigarettes research
Vapours vs cigarettes researchVapours vs cigarettes research
Vapours vs cigarettes research
 
E-Cigarettes: An Evidence Update
E-Cigarettes: An Evidence UpdateE-Cigarettes: An Evidence Update
E-Cigarettes: An Evidence Update
 
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022
 
E-cigarettes, California, basic information and legislative and regulatory su...
E-cigarettes, California, basic information and legislative and regulatory su...E-cigarettes, California, basic information and legislative and regulatory su...
E-cigarettes, California, basic information and legislative and regulatory su...
 
E-cig/Vaping fundamentals and CA legislation Aug 2014
E-cig/Vaping fundamentals and CA legislation Aug 2014E-cig/Vaping fundamentals and CA legislation Aug 2014
E-cig/Vaping fundamentals and CA legislation Aug 2014
 
How dangerous are e cigarette.pdf
How dangerous are e cigarette.pdfHow dangerous are e cigarette.pdf
How dangerous are e cigarette.pdf
 
Tobacco Harm Reduction - an introduction
Tobacco Harm Reduction - an introductionTobacco Harm Reduction - an introduction
Tobacco Harm Reduction - an introduction
 

More from Institute of Public Health in Ireland

Thomas T Prohaska
Thomas T ProhaskaThomas T Prohaska
Theo van Tilberg
Theo van TilbergTheo van Tilberg
Christina Victor
Christina VictorChristina Victor
James Lubben
James LubbenJames Lubben
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Institute of Public Health in Ireland
 
Prof. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College DublinProf. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College Dublin
Institute of Public Health in Ireland
 
Vanda Cummins, Health Service Executive
Vanda Cummins, Health Service ExecutiveVanda Cummins, Health Service Executive
Vanda Cummins, Health Service Executive
Institute of Public Health in Ireland
 
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Institute of Public Health in Ireland
 
Dr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General PractitionersDr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General Practitioners
Institute of Public Health in Ireland
 
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae HospitalAnne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Institute of Public Health in Ireland
 
Dr Andrew O'Regan
Dr Andrew O'ReganDr Andrew O'Regan
Alan Donnelly
Alan DonnellyAlan Donnelly
Seamus Nugent
Seamus NugentSeamus Nugent
Michael Mc Corry
Michael Mc CorryMichael Mc Corry
Andrew Boyd
Andrew BoydAndrew Boyd
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern IrelandProf. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Institute of Public Health in Ireland
 
Dr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to childrenDr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to children
Institute of Public Health in Ireland
 
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of HealthDr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Institute of Public Health in Ireland
 
Rita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & SkillsRita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & Skills
Institute of Public Health in Ireland
 
Paul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education CentrePaul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education Centre
Institute of Public Health in Ireland
 

More from Institute of Public Health in Ireland (20)

Thomas T Prohaska
Thomas T ProhaskaThomas T Prohaska
Thomas T Prohaska
 
Theo van Tilberg
Theo van TilbergTheo van Tilberg
Theo van Tilberg
 
Christina Victor
Christina VictorChristina Victor
Christina Victor
 
James Lubben
James LubbenJames Lubben
James Lubben
 
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
Lessons from MESAS: Monitoring and Evaluating Scotland's Alcohol Strategy (ME...
 
Prof. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College DublinProf. Shane O'Mara - Trinity College Dublin
Prof. Shane O'Mara - Trinity College Dublin
 
Vanda Cummins, Health Service Executive
Vanda Cummins, Health Service ExecutiveVanda Cummins, Health Service Executive
Vanda Cummins, Health Service Executive
 
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
Maurice Dillon Health Service Executive & Julie Broderick, Trinity College Du...
 
Dr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General PractitionersDr. Chris Leggett - Royal College of General Practitioners
Dr. Chris Leggett - Royal College of General Practitioners
 
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae HospitalAnne Gallagher -  Cardiac Rehabilitation Team, Mater Misericordiae Hospital
Anne Gallagher - Cardiac Rehabilitation Team, Mater Misericordiae Hospital
 
Dr Andrew O'Regan
Dr Andrew O'ReganDr Andrew O'Regan
Dr Andrew O'Regan
 
Alan Donnelly
Alan DonnellyAlan Donnelly
Alan Donnelly
 
Seamus Nugent
Seamus NugentSeamus Nugent
Seamus Nugent
 
Michael Mc Corry
Michael Mc CorryMichael Mc Corry
Michael Mc Corry
 
Andrew Boyd
Andrew BoydAndrew Boyd
Andrew Boyd
 
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern IrelandProf. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
Prof. Kevin Balanda - Lifetime costs of childhood obesity in Northern Ireland
 
Dr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to childrenDr. Mimi Tatlow-Golden - food marketing to children
Dr. Mimi Tatlow-Golden - food marketing to children
 
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of HealthDr. Liz Redmond & Mr. Gary Maxwell - Department of Health
Dr. Liz Redmond & Mr. Gary Maxwell - Department of Health
 
Rita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & SkillsRita Sexton - Department of Education & Skills
Rita Sexton - Department of Education & Skills
 
Paul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education CentrePaul Butler – Director, Mayo Education Centre
Paul Butler – Director, Mayo Education Centre
 

Recently uploaded

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 

Recently uploaded (20)

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 

E-Cigarettes - How should Public Health respond? - Linda Bauld

  • 1. Electronic cigarettes:Electronic cigarettes: how should public healthhow should public health respond?respond? Linda BauldLinda Bauld With thanks to Maciej L. Goniewicz, John Britton, Robert West & Martin Dockrell
  • 2. BackgroundBackground  In order to consider how and where e-cigarettesIn order to consider how and where e-cigarettes feature in the current public health landscape,feature in the current public health landscape, it’s important to take into account recentit’s important to take into account recent developments indevelopments in tobacco harm reductiontobacco harm reduction  Harm reduction measures are aimed at thoseHarm reduction measures are aimed at those smokers who, for whatever reason, are not ablesmokers who, for whatever reason, are not able or willing toor willing to stop using tobaccostop using tobacco oror stop using nicotine.stop using nicotine.
  • 4. NICE & Licensed Nicotine Products  The harm reduction approaches in the NICE guidanceThe harm reduction approaches in the NICE guidance can involve substituting the nicotine in tobacco withcan involve substituting the nicotine in tobacco with nicotine from less harmful, nicotine-containing products.nicotine from less harmful, nicotine-containing products.  These include NRT products that are licensed by theThese include NRT products that are licensed by the MHRA as pharmaceutical treatments for smoking.MHRA as pharmaceutical treatments for smoking.  There are also unregulated products such as electronicThere are also unregulated products such as electronic cigarettes. The guidance only recommends use of licensedcigarettes. The guidance only recommends use of licensed products recognising that when electronic cigarettesproducts recognising that when electronic cigarettes become licensed, they can be recommended for use.become licensed, they can be recommended for use.  Nicotine-containing products might be used eitherNicotine-containing products might be used either temporarily or indefinitely and as a partial or completetemporarily or indefinitely and as a partial or complete substitute for tobaccosubstitute for tobacco
  • 5. NICE & Nicotine-containing productsNICE & Nicotine-containing products The guidance states that:The guidance states that: There is reason to believe that lifetime use of licensedThere is reason to believe that lifetime use of licensed nicotine-containing products will be considerably lessnicotine-containing products will be considerably less harmful than smokingharmful than smoking There is little direct evidence on the effectiveness, qualityThere is little direct evidence on the effectiveness, quality and safety of nicotine-containing products that are notand safety of nicotine-containing products that are not regulated by the MHRA. However, they are expected to beregulated by the MHRA. However, they are expected to be less harmful than tobacco.less harmful than tobacco.
  • 6. Hon Lik: inventor of the Ruyan (“Hon Lik: inventor of the Ruyan (“resembling smoking”resembling smoking” )) e-cigarette, marketed 2004e-cigarette, marketed 2004
  • 7. Anatomy ofAnatomy of anan e-cigarettee-cigarette
  • 9. Growth in useGrowth in use  There are now an estimated 2.1 million users in the UKThere are now an estimated 2.1 million users in the UK  In the Republic of Ireland in 2012 the EurobarometerIn the Republic of Ireland in 2012 the Eurobarometer survey found that 3% of the Irish population had eversurvey found that 3% of the Irish population had ever tried e-cigarettes and 1% used them regularlytried e-cigarettes and 1% used them regularly  In the UK by 2014 ever use rose by a factor of 1.9 andIn the UK by 2014 ever use rose by a factor of 1.9 and current use by 1.7. If a similar rise happened in Ireland,current use by 1.7. If a similar rise happened in Ireland, we can assume 1.7% of the population regularly use ecigswe can assume 1.7% of the population regularly use ecigs and 5.6% have ever tried themand 5.6% have ever tried them  Amongst smokers in Ireland, we can estimate that aroundAmongst smokers in Ireland, we can estimate that around 1/3 (34%) have tried them but the figure may now be1/3 (34%) have tried them but the figure may now be higher.higher. Source: Eurobarometer and personal correspondence with Fenton Howell
  • 10. Stop smoking aids (England)Stop smoking aids (England) Source: West et al (2014) www.smokinginengland.info/lateststatistics 20% use NRT from store 25% use e-cig 40% use nothing
  • 11. • nicotine • propylen glycol • glycerin • water • flavourings What is in a cartridge ?
  • 12. • The Food and Drug Administration (FDA) has classified PG as an additive that is “generally recognized as safe” for use in food. • It is used to absorb extra water and maintain moisture in certain medicines, cosmetics, or food products. • PG is also used to create artificial smoke or fog used in theatrical productions. • PG is practically odorless and tasteless. PropylenPropylenee GlycolGlycol
  • 13. Current e-cigarette use amongCurrent e-cigarette use among adults in England 2014adults in England 2014 13 ASH/YouGov March April 2014, Sample in England 10,112
  • 14. Nicotine use by never smokersNicotine use by never smokers and long-term ex-smokersand long-term ex-smokers Source: West et al, 2014 N=5,272 from Nov 2013 E-cigarette use by never smokers is negligible
  • 15. Use by children?Use by children?
  • 16. Survey of children in GB 2013Survey of children in GB 2013 95% 90% 4% 8% 1% 1% 0% 1% 0% 25% 50% 75% 100% 11to15(N=804)16to18(N=624) I use them often (more than once a week) I use them sometimes (more than once a month) I have tried them once or twice I have never used them 99% 92% 82% 74% 59% 39% 8% 7% 18% 37% 48% 6% 4% 7%4% 5% 0% 25% 50% 75% 100% Never smoked Tried smoking once Used to smoke Smoke <1 a week Smoke 1-6 a week Smoke 6+ a week Don't know/ Wouldn't say I use them often (more than once a week) I use them sometimes (more than once a month) I have tried them once or twice I have never used them Source: ASH, 2014 Frequency of e-cigarette use amongst 11-18 year olds who had ever heard of e-cigs E-cigarette use by smoking status, 11-18 year olds
  • 17. E-cigarette/smoking by children: USAE-cigarette/smoking by children: USA Source: US CDC data from National Youth Tobacco Survey 2011 and 2012. Graph from Bates & Rodu
  • 20. Do e-cigarettes deliver nicotine? E-cigarettes generate vapor that contains nicotine, but e-cigarettes brands and models differ in efficacy and consistency of nicotine vaporization. In e-cigarettes that vaporize nicotine effectively, the amount inhaled from 15 puffs is lower than smoking a conventional cigarette.
  • 21. Toxicants in e-cigarettes?Toxicants in e-cigarettes?  Other than nicotine, whatOther than nicotine, what else do e-cigarettes deliver?else do e-cigarettes deliver?  A number of studies haveA number of studies have looked at this, with at least 8looked at this, with at least 8 toxic compounds identifiedtoxic compounds identified  However all of these were atHowever all of these were at significantly lower levels thansignificantly lower levels than in conventional cigarettesin conventional cigarettes
  • 22. • Small study conducted by Goniewcz and colleagues involving 20 tobacco cigarette smokers • Subjects were provided with electronic cigarettes with cartridges containing nicotine • Subjects were asked to substitute their regular cigarettes with e-cigarettes for 2 weeks • Researchers measured nicotine and selected carcinogens in their bodies Exposure to toxicantsExposure to toxicants after switchingafter switching
  • 23. Nicotine & Tobacco-specificNicotine & Tobacco-specific NitrosaminesNitrosamines
  • 24. What about the vapour?What about the vapour?  Should we be concerned about e-cigaretteShould we be concerned about e-cigarette vapour in enclosed public places?vapour in enclosed public places?  Lab studies suggest that the vapour containsLab studies suggest that the vapour contains nicotine and some toxic metals such as cadium,nicotine and some toxic metals such as cadium, nickel and lead, but levels are much lower thannickel and lead, but levels are much lower than in second hand smokein second hand smoke  No current evidence of health harms fromNo current evidence of health harms from occasional exposureoccasional exposure  However the effects of regular exposure overHowever the effects of regular exposure over many years is unknown.many years is unknown.
  • 25. Cessation: RCTs of E-cigarettesCessation: RCTs of E-cigarettes • ‘‘Categoria’ 7.2mg nicotine EC vs. 4.8mgCategoria’ 7.2mg nicotine EC vs. 4.8mg nicotine EC vs. no nicotine ECnicotine EC vs. no nicotine EC  300 smokers (unwilling to quit)300 smokers (unwilling to quit)  1 year abstinence rates: 13%, 9% and 4%1 year abstinence rates: 13%, 9% and 4% (Caponnetto et al. 2013)(Caponnetto et al. 2013) • ‘‘Elusion’ 16mg nicotine EC vs. nicotineElusion’ 16mg nicotine EC vs. nicotine patch vs. no nicotine ECpatch vs. no nicotine EC  657 participants657 participants  6 month abstinence rates: 7.3%, 5.8% and6 month abstinence rates: 7.3%, 5.8% and 4.1%4.1% (Bullen et al. 2013)(Bullen et al. 2013)
  • 26. Effectiveness in EnglandEffectiveness in England Source: West et al (2014) www.smokinginengland.info/lateststatistics E-cigarette users were more likely not to be smoking than those using NRT bought from a store and those using nothing ** ** Significantly different from both other groups
  • 27. After adjusting for differencesAfter adjusting for differences between groupsbetween groups Source: West et al (2014) www.smokinginengland.info/lateststatistics The odds of e-cigarette users still being abstinent were 61% greater than those using nothing and 63% greater than those using NRT
  • 28. Success rates of differentSuccess rates of different methods of quittingmethods of quitting LowestLowest  Nothing or NRT bought from aNothing or NRT bought from a storestore  HigherHigher  Prescription NRT/medicine or e-Prescription NRT/medicine or e- cigarette from a store (about 50%cigarette from a store (about 50% better)better)  HighestHighest  Specialist support from NHSSpecialist support from NHS Stop-Smoking Service (aboutStop-Smoking Service (about 200% better)200% better)
  • 29. There has been an increase in the rate of quitting smoking More smokers are quittingMore smokers are quitting •Source: West et al, 2014 ENGLAND ONLY Base: All adults
  • 30. Cigarette consumption has decreased as has overall nicotine use Fewer people are using nicotineFewer people are using nicotine •Source: West et al, 2014 ENGLAND ONLY Base: All adults
  • 31. Cigarette smoking prevalenceCigarette smoking prevalence Source: West et al, 2014 ENGLAND ONLY Base: All adults Prevalence is declining faster than in previous years since 2008
  • 32. A licensed product?A licensed product? NicoventuresNicoventuresVokeVoke inhaled nicotineinhaled nicotine
  • 33. RegulationRegulation  Medicine’s “walledMedicine’s “walled garden”?garden”? • ““Safe” and “effective”Safe” and “effective” • Therapeutic doseTherapeutic dose • AdvertisingAdvertising • VAT 5%VAT 5%  EU’s “NicotineEU’s “Nicotine Jungle”?Jungle”? • Health warning on packHealth warning on pack • Concentration capConcentration cap • No health claimsNo health claims • Ad banAd ban • 20% VAT20% VAT • Declaration of additivesDeclaration of additives
  • 34. Points for discussionPoints for discussion • In the struggle to reduce preventable mortality, how do weIn the struggle to reduce preventable mortality, how do we balance the risks?balance the risks? • What are the ongoing evidence needs and how do we addressWhat are the ongoing evidence needs and how do we address them?them? • Do we need to test diverse responses or do we need a “oneDo we need to test diverse responses or do we need a “one size fits all” international response now?size fits all” international response now? • How do we manage tobacco industry involvement and whatHow do we manage tobacco industry involvement and what scope is there to use the Framework Convention on Tobaccoscope is there to use the Framework Convention on Tobacco Control?Control?

Editor's Notes

  1. The device uses heat to vaporize a propylene glycol- or glycerin-based liquid solution into a mist, similar to the way a nebulizer or humidifier vaporizes solutions for inhalation. The device&amp;apos;s components usually include a small liquid reservoir, a heating element, and a power source, normaly a battery
  2. The device uses heat to vaporize a propylene glycol- or glycerin-based liquid solution into a mist, similar to the way a nebulizer or humidifier vaporizes solutions for inhalation. The device&amp;apos;s components usually include a small liquid reservoir, a heating element, and a power source, normaly a battery
  3. Use amongst 11-18 year-olds 7% had tried e-cigarettes at least once 2% reported using them ‘sometimes’ (more than once a month) or ‘often’ (more than once a week) 28% of those who had ever used e-cigarettes, had used them within the last month   Use by age 16-18 years: 11% had tried e-cigarettes at least once; 8% reported using them sometimes; and 1% using them often 11-15 years: 4% had tried them at least once and 1% reported using them sometimes; none reported more frequent use. 95% 11-15 year-olds and 90% 16-18 year-olds had never used e-cigarettes  
  4. So, in our survey of just under 6,000 smokers we found that…A total of…
  5. Therefore, the key finding is the result after we adjust for differences in a range of socio-demog and smoker characteristics. In these adjusted models, we found that…